Cargando…

A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: SARS-CoV2 infection leads to a concomitant pulmonary inflammation. This inflammation is supposed to be the main driver in the pathogenesis of lung failure (Acute Respiratory Distress Syndrome) in COVID-19. Objective of this study is to evaluate the efficacy and safety of a single dose tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rilinger, Jonathan, Kern, Winfried V., Duerschmied, Daniel, Supady, Alexander, Bode, Christoph, Staudacher, Dawid L., Wengenmayer, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267747/ https://www.ncbi.nlm.nih.gov/pubmed/32493514 http://dx.doi.org/10.1186/s13063-020-04447-3

Ejemplares similares

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial
por: Rieder, Marina, et al.
Publicado: (2021)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation
por: Rieder, Marina, et al.
Publicado: (2020)

Extracorporeal membrane oxygenation in Pneumocystis jirovecii pneumonia: outcome in HIV and non-HIV patients
por: Rilinger, Jonathan, et al.
Publicado: (2019)

Mobile ECMO retrieval of patients during the COVID‐19 pandemic
por: Widmeier, Eugen, et al.
Publicado: (2021)

Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid‐19 or influenza: A single‐center registry study
por: Jäckel, Markus, et al.
Publicado: (2020)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial
por: Supady, Alexander, et al.
Publicado: (2021)

Advantages of score-based delirium detection compared to a clinical delirium assessment—a retrospective, monocentric cohort study
por: Jäckel, Markus, et al.
Publicado: (2021)

Hospital networks and patient transport capacity during the COVID-19 pandemic when intensive care resources become scarce
por: Supady, Alexander, et al.
Publicado: (2021)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

THE DURATION OF MECHANICAL VENTILATION PRIOR TO VV-ECMO IN PATIENTS WITH COVID-19 DOES NOT HAVE AN IMPACT ON SURVIVAL DURING THREE WAVES OF THE PANDEMIC
por: WIDMEIER, E., et al.
Publicado: (2022)

Long-term survival and health-related quality of life in patients with severe acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation support
por: Rilinger, Jonathan, et al.
Publicado: (2021)

Delirium in Critically Ill Patients with and without COVID-19—A Retrospective Analysis
por: Jäckel, Markus, et al.
Publicado: (2021)

Myocarditis mortality with and without COVID-19: insights from a national registry
por: Bemtgen, Xavier, et al.
Publicado: (2022)

Combining lung ultrasound and Wells score for diagnosing pulmonary embolism in critically ill COVID-19 patients
por: Zotzmann, Viviane, et al.
Publicado: (2020)

Admission blood glucose level and outcome in patients requiring venoarterial extracorporeal membrane oxygenation
por: Bemtgen, Xavier, et al.
Publicado: (2021)

Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience
por: Zotzmann, Viviane, et al.
Publicado: (2019)

Incidence and predictors of delirium on the intensive care unit in patients with acute kidney injury, insight from a retrospective registry
por: Jäckel, Markus, et al.
Publicado: (2021)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
por: Cotter, Aoife, et al.
Publicado: (2020)

Mode of Death after Extracorporeal Cardiopulmonary Resuscitation
por: Zotzmann, Viviane, et al.
Publicado: (2021)

Influence of immunosuppression in patients with severe acute respiratory distress syndrome on veno‐venous extracorporeal membrane oxygenation therapy
por: Rilinger, Jonathan, et al.
Publicado: (2021)

Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19
por: Bemtgen, Xavier, et al.
Publicado: (2020)

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
por: Burmester, Gerd R, et al.
Publicado: (2016)

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Publicado: (2021)

Carboxyhemoglobin (CO-Hb) Correlates with Hemolysis and Hospital Mortality in Extracorporeal Membrane Oxygenation: A Retrospective Registry
por: Bemtgen, Xavier, et al.
Publicado: (2022)

Choosing the right reference cohort for assessing outcome of venovenous ECMO
por: Supady, Alexander, et al.
Publicado: (2022)

Trial of intraoperative cell salvage versus transfusion in ovarian cancer (TIC TOC): protocol for a randomised controlled feasibility study
por: Galaal, Khadra, et al.
Publicado: (2018)

Influence of low-flow time on survival after extracorporeal cardiopulmonary resuscitation (eCPR)
por: Wengenmayer, Tobias, et al.
Publicado: (2017)

Procedural justice and egalitarian principles for rationing decisions in the COVID-19 crisis
por: Supady, Alexander, et al.
Publicado: (2020)

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial
por: McMahon, James H., et al.
Publicado: (2020)

Impact of pulse pressure on clinical outcome in extracorporeal cardiopulmonary resuscitation (eCPR) patients
por: Rilinger, Jonathan, et al.
Publicado: (2021)

Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 Patients
por: Lang, Corinna N, et al.
Publicado: (2021)

Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study
por: Lang, Corinna N., et al.
Publicado: (2020)

Prone positioning in severe ARDS requiring extracorporeal membrane oxygenation
por: Rilinger, Jonathan, et al.
Publicado: (2020)

On the Use of Hemadsorption with CytoSorb in Patients with Septic Shock. Comment on Kogelmann et al. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. J. Clin. Med. 2021, 10, 2939
por: Supady, Alexander, et al.
Publicado: (2022)

How to treat combined respiratory and metabolic acidosis after extracorporeal cardiopulmonary resuscitation?
por: Bemtgen, Xavier, et al.
Publicado: (2019)

Extracorporeal membrane oxygenation during the first three waves of the coronavirus disease 2019 pandemic—A retrospective single‐center registry study
por: Widmeier, Eugen, et al.
Publicado: (2022)

Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial
por: Maláska, Jan, et al.
Publicado: (2021)

A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
por: Khan, Farhan Raza, et al.
Publicado: (2020)

Survival outcomes and mobilization during venovenous extracorporeal membrane oxygenation: a retrospective cohort study
por: Rottmann, Felix A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5atqrtmgmr415lve1od0vr633p